Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Jul 17, 2026, 3:54 PM EST
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $2.31 thousand as of September 8, 2026. Its market cap has decreased by -99.92% in one year.
Market Cap
2.31K
Enterprise Value
-1.59M
Revenue
389.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 2.31K, a decrease of -99.99%. That is a compound annual growth rate of -92.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 2.31K | -99.72% |
| Dec 31, 2025 | 831.75K | -77.44% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xeno Transplants | 4.04K |
| eFFECTOR Therapeutics | 3.76K |
| Synovics Pharmaceuticals | 3.65K |
| Innoveren Scientific | 3.20K |
| Hemagen Diagnostics | 3.10K |
| TetraLogic Pharmaceuticals | 2.43K |
| OncoVista Innovative Therapies | 2.36K |
| Suvanza Pharma, LLC | 2.24K |